In batch no. 0-20022AB an out-of-specification result was found due to the presence of visible particles in the product intended for solution for injection. Potential effects: embolism, inflammation, inflammatory reactions, local or systemic complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from batch 0-20022AB. Entities holding this batch should immediately stop its use and return it to the wholesaler. Patients who received the product from this batch and experien...
The Chief Pharmaceutical Inspector withdrew batch 0-20022AB of Mitocin 20 mg from the market throughout the country and granted the decision immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related